Cargando…

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review

Alzheimer’s disease (AD) is a progressive neurodegenerative disease and accounts for most cases of dementia. The prevalence of AD has increased in the current rapidly aging society and contributes to a heavy burden on families and society. Despite the profound impact of AD, current treatments are un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Tien-Wei, Lane, Hsien-Yuan, Lin, Chieh-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348485/ https://www.ncbi.nlm.nih.gov/pubmed/34360973 http://dx.doi.org/10.3390/ijms22158208

Ejemplares similares

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Novel Biomarkers of Alzheimer’s Disease: Based Upon N-methyl- D-aspartate Receptor Hypoactivation and Oxidative Stress
por: Chiang, Ting-I, et al.
Publicado: (2021)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease
por: Huang, Yu-Jhen, et al.
Publicado: (2012)

Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease
por: Lane, Hsien‐Yuan, et al.
Publicado: (2022)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

A Review on Phyto-Therapeutic Approaches in Alzheimer’s Disease
por: Sahiner, Mehtap, et al.
Publicado: (2023)

An update on the novel and approved drugs for Alzheimer disease
por: Alhazmi, Hassan Ahmad, et al.
Publicado: (2022)

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

Bupropion interferes with the image diagnosis of Parkinson’s disease
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design
por: Lin, Eugene, et al.
Publicado: (2020)

Neuroinflammation and Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
por: Sung, Pi-Shan, et al.
Publicado: (2020)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
por: Huang, Yu-Jhen, et al.
Publicado: (2017)

Therapeutic apheresis in kidney diseases: an updated review
por: Chen, Yi-Yuan, et al.
Publicado: (2022)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Molecular Basis of Late-Life Depression
por: Kuo, Chien-Yi, et al.
Publicado: (2021)

Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer’s disease: an updated overview of nonpharmacological therapies
por: Formolo, Douglas A., et al.
Publicado: (2023)

Updates on p53: modulation of p53 degradation as a therapeutic approach
por: Dey, A, et al.
Publicado: (2008)

New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

Circadian dysfunction and Alzheimer's disease – An updated review
por: Ahmad, Faizan, et al.
Publicado: (2022)

Exosomes: a novel therapeutic target for Alzheimer’s disease?
por: Cai, Zhi-You, et al.
Publicado: (2018)

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
por: Ejaz, Hafza Wajeeha, et al.
Publicado: (2020)

Updated Functional Roles of NAMPT in Carcinogenesis and Therapeutic Niches
por: Lin, Tsung-Chieh
Publicado: (2022)

An Update on Apathy in Alzheimer’s Disease
por: Dolphin, Helena, et al.
Publicado: (2023)

Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update
por: Jan, Arif Tasleem, et al.
Publicado: (2017)

Therapeutic Approaches to Delay the Onset of Alzheimer's Disease
por: Kumar, Raj, et al.
Publicado: (2011)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68ilcb7eg0cb0occlekc58o3bi